Compounds > azacitidine

azacitidine and HIV Coinfection

azacitidine has been researched along with HIV Coinfection in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (9.09)	18.2507
2000's	2 (18.18)	29.6817
2010's	6 (54.55)	24.3611
2020's	2 (18.18)	2.80

Authors

Authors	Studies
Bonnac, L; Clouser, CL; Daly, MB; Kim, B; Landman, SR; Mansky, LM; Patterson, SE; Rawson, JM; Reilly, CS; Roth, ME; Xie, J	1
Chiba, DE; Dos Santos, JL; Lopes, JR	1
Daly, MB; Greggs, WM; Kim, B; Mansky, LM; McDaniel, YZ; Patterson, SE; Roth, M; Talledge, N	1
Ackley, A; Bosque, A; Clemson, M; Famiglietti, M; Morris, KV; Planelles, V; Saayman, S; Turner, AW	1
Commenges, D; Prague, M; Thiébaut, R	1
Bonnac, L; Landman, SR; Mansky, LM; Patterson, SE; Rawson, JM; Reilly, CS	1
Clouser, CL; Mansky, LM; Patterson, SE	1
Krečmerová, M; Otmar, M	1
Choi, BI; Ishida, T; Iwakura, Y; Tanaka, J; Watanabe, T; Yasuda, J	1
Brabant, W; Daifuku, R; Gall, A; Harris, KS; Styrchak, S	1
Birx, DL; Boswell, RN; Burke, DS; Kim, JH; McLinden, RJ; Mosca, JD; Redfield, RR	1

Reviews

2 review(s) available for azacitidine and HIV Coinfection

Article	Year
HIV latency reversal agents: A potential path for functional cure? European journal of medicinal chemistry, 2021, Mar-05, Volume: 213 Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Molecular Structure; Virus Latency	2021
5-azacytosine compounds in medicinal chemistry: current stage and future perspectives. Future medicinal chemistry, 2012, Volume: 4, Issue:8 Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Azacitidine; Cytosine; DNA Methylation; Drug Discovery; HIV; HIV Infections; Humans; Neoplasms	2012

Other Studies

9 other study(ies) available for azacitidine and HIV Coinfection

Article	Year
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & medicinal chemistry, 2016, 06-01, Volume: 24, Issue:11 Topics: Anti-HIV Agents; Azacitidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Ribonucleotide Reductases; Structure-Activity Relationship	2016
Distinct Antiretroviral Mechanisms Elicited by a Viral Mutagen. Journal of molecular biology, 2021, 09-03, Volume: 433, Issue:18 Topics: Animals; Antiviral Agents; Azacitidine; Cats; Cytidine Triphosphate; HIV; HIV Infections; Humans; Leukemia Virus, Feline; Leukemia Virus, Murine; Leukemia, Experimental; Mice; Mutagenesis; Mutagens; Mutation; Retroviridae Infections; Tumor Virus Infections; Virus Replication	2021
An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Molecular therapy : the journal of the American Society of Gene Therapy, 2014, Volume: 22, Issue:6 Topics: Azacitidine; Epigenesis, Genetic; Gene Expression Regulation, Viral; HEK293 Cells; HIV Infections; HIV-1; Humans; Hydroxamic Acids; Jurkat Cells; Promoter Regions, Genetic; RNA, Antisense; RNA, Long Noncoding; RNA, Messenger; RNA, Viral	2014
[Mathematical dynamical models for personalized medicine]. Medecine sciences : M/S, 2014, Volume: 30 Spec No 2 Topics: Anti-HIV Agents; Azacitidine; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dideoxynucleosides; HIV Infections; HIV-1; HLA-B Antigens; Humans; Lamivudine; Models, Theoretical; Precision Medicine; Receptors, CCR5; Reverse Transcriptase Inhibitors; Virus Attachment	2014
Lack of mutational hot spots during decitabine-mediated HIV-1 mutagenesis. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11 Topics: Azacitidine; Cell Line; Decitabine; HIV Infections; HIV-1; Humans; Mutagenesis; Mutation; Mutation Rate	2015
Exploiting drug repositioning for discovery of a novel HIV combination therapy. Journal of virology, 2010, Volume: 84, Issue:18 Topics: Anti-HIV Agents; Azacitidine; Decitabine; Deoxycytidine; Drug Interactions; Drug Therapy, Combination; Gemcitabine; HIV; HIV Infections; Humans; Mutation	2010
Latent HIV-1 reactivation in transgenic mice requires cell cycle -dependent demethylation of CREB/ATF sites in the LTR. AIDS (London, England), 2003, Jan-24, Volume: 17, Issue:2 Topics: Activating Transcription Factors; Animals; Azacitidine; Blood Proteins; Cell Cycle; CpG Islands; Cyclic AMP Response Element-Binding Protein; DNA Methylation; DNA, Viral; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation, Viral; HIV Infections; HIV Long Terminal Repeat; HIV-1; Lipopolysaccharides; Mice; Mice, Inbred C3H; Mice, Transgenic; Transcription Factors; Viral Proteins; Virus Latency	2003
KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis. Antiviral research, 2005, Volume: 67, Issue:1 Topics: Animals; Anti-HIV Agents; Azacitidine; Cell Line; Cricetinae; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Nucleosides; Reverse Transcriptase Inhibitors; Zidovudine	2005
Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1996, Aug-01, Volume: 12, Issue:4 Topics: Amino Acid Sequence; Antimetabolites, Antineoplastic; Azacitidine; Base Sequence; Blotting, Southern; Cloning, Molecular; DNA, Viral; Gene Products, tat; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Polymerase Chain Reaction; Proviruses; Repetitive Sequences, Nucleic Acid; RNA, Messenger; RNA, Viral; Superinfection; T-Lymphocytes; tat Gene Products, Human Immunodeficiency Virus; Tetradecanoylphorbol Acetate; Transcription, Genetic; Up-Regulation	1996